![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 5.png)
기존 트로포닌 분석 대비 hs-cTn 분석의 이점
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 6.png)
기존 트로포닌 분석과 비교해 hs-cTn 분석은 다음의
이점이 있습니다.1
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 42.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 10.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 10.png)
내원 시 MI 감별 민감도가 더 높음
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 43.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 43.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 43.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 20.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 20.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 20.png)
AMI에 대한 음성 예측값이 더 높음
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 44.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 44.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 44.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 9.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 9.png)
2회의 cTn 측정 간 간격이 더 짧음
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 45.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 45.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 45.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 19.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 19.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 19.png)
기존 분석을 사용하여 cTn을 검출할 수 없었던 환자를 확인할 수 있음
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 15.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 15.png)
고감도 심장 트로포닌의 가치2
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 42.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 42.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 42.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 20.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 20.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 20.png)
MI를 조기에 발견함
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 43.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 43.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 43.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 19.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 19.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 19.png)
MI “rule-in” 및 “rule-out”을 보다 빠르게 할 수 있음
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 44.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 44.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 44.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 16.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 16.png)
제1형 MI와 제II형 MI를 더 많이 발견할 수 있음
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 45.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 45.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 45.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 17.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 17.png)
불안정 협심증 진단을 감소시킴
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 26.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 26.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 18.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 18.png)
저비용으로 정확성이 향상됨
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 22.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 22.png)
심근세포 손상의 정량적 표지자
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
hs-cTn 분석은 건강한 집단의 상당 비율에서 심장 트로포닌을 검출할 수
있습니다.1
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
MI 외에도 cTn 수치 증가와 관련될 수 있는 여러 다른 상태가
있습니다.1
급성 제1형 MI 외에 cTn 상승을 유발하는 심근 손상과 관련된 다른 상태1
부정빈맥, 심부전, 고혈압 응급증, 중대한 질병, 심근염, 타코츠보 증후군, 판막성 심장 질환, 대동맥 박리, 폐색전증
신장 기능장애가 있는 노인 환자들에서, 만성 관상동맥 증후군 또는 고혈압 심장 질환은 심장 트로포닌 농도 상승의 가장 빈번한 원인입니다.
cTn 수치 증가 및/또는 감소 평가는 심근세포 손상과 관련된 다른 상태로부터 MI를 구별하는 데 도움이 될 수
있습니다1,3
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-25.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-25.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 25.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset 25.png)
고효율 진단 검사 분석 vs. POCT
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
자동 플랫폼에서 실행되는 심장 트로포닌 분석은 주로 민감하거나 매우 민감한
분석입니다.1
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-hs-cTn-Assays-Infographic-2108-Asset-21-new.png.png)
현재 사용 중인 대부분의 POCT는 민감하거나 매우 민감한 분석으로 간주되지 않습니다.
자동 분석이 선호됩니다.1
ESC 2020은 hs-cTn 외에 CK, CK-MB, h-FABP 또는 코펩틴과 같은 생체표지자 사용을 권장하지 않습니다.1
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 20.png)
![](https://dianews.roche.com/rs/106-RRW-330/images/CTL-ESC2020-Infographic-2108-Asset 20.png)